At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
CP1110 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pre-Marketing, Prospective, Multi-Site, Open-Label, Within-Subject, Feasibility, Interventional Study of Speech Perception With Experienced Adult Cochlear Implant Recipients Using the CP1110 Sound Processor and Compared With the CP1000 Sound Processor
In Brief
A clinical study evaluating CP1110 and CP1000 for Adult Cochlear Implant Recipients. Completed, enrolled 21 participants across 1 site.
Detailed Summary
The clinical study aims to investigate the speech performance with the CP1110 Sound Processor, compared with the CP1000 Sound Processor, and inclusion of a noise reduction feature in the Automatic Scene Classifier..
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdult Cochlear Implant Recipients
CountriesAustralia
CollaboratorsAvania
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMay 2021
Enrollment StartOct 2021
Primary CompletionDec 2021
TodayJul 2026
First PostedMay 24, 2021
Enrollment StartOct 25, 2021
Primary CompletionDec 16, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.1 years ago
Interventions
CP1110device
Sound Processor
CP1000device
Sound Processor